Khutoryansky NM - Search Results

1

Exploratory study on the reversal of warfarin with rFVIIa in healthy subjects.

Skolnick BE, Mathews DR, Khutoryansky NM, Pusateri AE, Carr ME. Skolnick BE, et al. Among authors: khutoryansky nm. Blood. 2010 Aug 5;116(5):693-701. doi: 10.1182/blood-2009-11-253492. Epub 2010 Apr 12. Blood. 2010. PMID: 20385794 Free article. Clinical Trial.

2

Reversal of clopidogrel-induced bleeding with rFVIIa in healthy subjects: a randomized, placebo-controlled, double-blind, exploratory study.

Skolnick BE, Shenouda M, Khutoryansky NM, Pusateri AE, Gabriel D, Carr ME. Skolnick BE, et al. Among authors: khutoryansky nm. Anesth Analg. 2011 Oct;113(4):703-10. doi: 10.1213/ANE.0b013e318228c690. Epub 2011 Sep 2. Anesth Analg. 2011. PMID: 21890888 Clinical Trial.

3

Absence of QTc prolongation in a thorough QT study with subcutaneous liraglutide, a once-daily human GLP-1 analog for treatment of type 2 diabetes.

Chatterjee DJ, Khutoryansky N, Zdravkovic M, Sprenger CR, Litwin JS. Chatterjee DJ, et al. J Clin Pharmacol. 2009 Nov;49(11):1353-62. doi: 10.1177/0091270009339189. Epub 2009 Sep 8. J Clin Pharmacol. 2009. PMID: 19737980 Clinical Trial.

4

Does serum 1,5-anhydroglucitol establish a relationship between improvements in HbA1c and postprandial glucose excursions? Supportive evidence utilizing the differential effects between biphasic insulin aspart 30 and insulin glargine.

Moses AC, Raskin P, Khutoryansky N. Moses AC, et al. Diabet Med. 2008 Feb;25(2):200-5. doi: 10.1111/j.1464-5491.2008.02384.x. Diabet Med. 2008. PMID: 18290862 Clinical Trial.

5

Recombinant activated factor VII in spinal surgery: a multicenter, randomized, double-blind, placebo-controlled, dose-escalation trial.

Sachs B, Delacy D, Green J, Graham RS, Ramsay J, Kreisler N, Kruse P, Khutoryansky N, Hu SS. Sachs B, et al. Spine (Phila Pa 1976). 2007 Oct 1;32(21):2285-93. doi: 10.1097/BRS.0b013e3181557d45. Spine (Phila Pa 1976). 2007. PMID: 17906567 Clinical Trial.

6

Evidence supporting an association between hypoglycemic events and depression.

Shao W, Ahmad R, Khutoryansky N, Aagren M, Bouchard J. Shao W, et al. Curr Med Res Opin. 2013 Dec;29(12):1609-15. doi: 10.1185/03007995.2013.830599. Epub 2013 Sep 23. Curr Med Res Opin. 2013. PMID: 23899102 Clinical Trial.

7

Combination therapy for type 2 diabetes: repaglinide plus rosiglitazone.

Raskin P, McGill J, Saad MF, Cappleman JM, Kaye W, Khutoryansky N, Hale PM; Repaglinide/Rosiglitazone Study Group. Raskin P, et al. Diabet Med. 2004 Apr;21(4):329-35. doi: 10.1111/j.1464-5491.2004.01143.x. Diabet Med. 2004. PMID: 15049934 Clinical Trial.

8

Efficacy and safety of combination therapy: repaglinide plus metformin versus nateglinide plus metformin.

Raskin P, Klaff L, McGill J, South SA, Hollander P, Khutoryansky N, Hale PM; Repaglinide vs. Nateglinide Metformin Combination Study Group. Raskin P, et al. Diabetes Care. 2003 Jul;26(7):2063-8. doi: 10.2337/diacare.26.7.2063. Diabetes Care. 2003. PMID: 12832314 Clinical Trial.

9

Repaglinide versus nateglinide monotherapy: a randomized, multicenter study.

Rosenstock J, Hassman DR, Madder RD, Brazinsky SA, Farrell J, Khutoryansky N, Hale PM; Repaglinide Versus Nateglinide Comparison Study Group. Rosenstock J, et al. Diabetes Care. 2004 Jun;27(6):1265-70. doi: 10.2337/diacare.27.6.1265. Diabetes Care. 2004. PMID: 15161773 Clinical Trial.

10

Accuracy and precision of the NovoPen 3 insulin delivery device after mechanical and temperature stresses.

Santiago OM, Khutoryansky NM, Bilbo CM, Lawton SA, Kristensen CM. Santiago OM, et al. Among authors: khutoryansky nm. Endocr Pract. 2002 Sep-Oct;8(5):351-5. doi: 10.4158/EP.8.5.351. Endocr Pract. 2002. PMID: 15251837

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters